American Association for Clinical Chemistry (AACC) 2022 Virtual Conference

Open to Public

Registration Required

Event Info Email

RSVP - nboddie@gmu.edu

The field of tissue spatial molecular profiling has reached a high level of sophistication. It offers a rich set of technologies, software, and protocols of interest to the American Association for Clinical Chemistry membership members.

Join us for this collaborative half-day symposium to learn about the latest cancer biomarker discoveries using these new tools, and have access to expert guidelines, standard protocols, and technology choices for their own specific intended uses.

View Event Invite

AGENDA

12:30 to 12:50 PM -  Introduction/Opening Remarks

Dr. Liotta, George Mason University

Spatial Tissue Molecular Profiling

12:50 to 1:20 PM

Dr. Eva Hedlund, Karolinska Institute

LCM-Seq, a novel spatially anchored, extraction-free method for single and multicellular RNA-seq in tissue

1:20 to 1:50 PM

Dr. Kevin Janes, University of Virginia

10cRNAseq with stochastic profiling for inferred single-cell expression in tissue

1:50 to 2:20 PM

Dr. Robert West, Stanford University

Spatial transcriptomics in FFPE clinical archival tissues with novel Smart-35eq method

2:20 to 2:30 PM -  BREAK

2:30 to 3:00 PM

Dr. Emanuel Petricoin, George Mason University

Spatial phospho-proteomic profiling of breast cancer predicts the likelihood that an individual patient's HER2postivie tumor will respond by complete pathologic response(PCR) to neoadjuvant HER2 therapies

3:00 to 3:30 PM

Dr. Michael T. Eadon, Indiana University Health Medical Center

Cellular and molecular interrogation of kidney biopsy specimens.

3:30 to 4:00 PM

Dr. R.M.A. Heeren, Maastrich University Netherlands

Combining LCM and imaging MS to achieve in-depth tissue multi-omics

4:00 to 4:30 PM

Dr. Shawn M. Davidson, Princeton University

Metabolomic spatial tissue profiling using imaging mass spectrometry

4:30 to 5:00 PM

Dr. Tom Conrads, INOVA Schar Cancer Institute

Intratumor Proteogenomic Heterogeneity Revealed by Multiregion Sampling in a High-Grade Serous Ovarian Tumor Specimen

5:00 to 5:30 PM -  Closing Remarks

Dr. Laura Esserman, UCSF

Interrogating the breast cancer microenvironment: driving therapeutic discovery using innovative clinical trial designs

View Event Invite